Evolution of the Average Target: Core Scientific, Inc.

Evolution of the Target Price: Core Scientific, Inc.

Changes in Analyst Recommendations: Core Scientific, Inc.

a8112cccbff3.S7ZtLCosMU03jk_K7sTfee6dJqQq6-GdJNTyRd7FRzs.foJbZmt1cjoB5z2PsaztEbr8F-ttkdP3fee5H7H1PkN83gpkYmZ3CwL_Gg~e6782e8a049f4b4c5b0870bfbc1ff543
08-03 B. Riley Adjusts Price Target on Core Scientific to $42 From $33, Maintain Buy Rating MT
07-30 Keefe Bruyette & Woods Upgrades Core Scientific to Outperform From Market Perform, Adjusts PT to $28 From $25 MT
07-29 Macquarie Adjusts Price Target on Core Scientific to $38 From $35, Maintains Outperform Rating MT
07-27 Keefe, Bruyette & Woods Downgrades Core Scientific to Market Perform From Outperform, Cuts Price Target to $25 From $28 MT
05-27 B. Riley Adjusts Price Target on Core Scientific to $33 From $30, Maintains Buy Rating MT
05-04 U.S. research roundup - Alphabet, Colgate-Palmolive, Welltower RE
03-05 Macquarie Cuts Price Target on Core Scientific to $28 From $34, Keeps Outperform Rating MT
01-06 BTIG Upgrades Core Scientific Inc to Buy From Neutral, Price Target is $23 MT
25-10-31 Core Scientific Well-Positioned to Gain New Customers, Macquarie Says MT
25-10-31 Macquarie Upgrades Core Scientific to Outperform From Neutral, Adjusts Price Target to $34 From $18 MT
25-10-30 Top Midday Stories: Trump, Xi Reach Trade Agreement; Meta Shares Tumble After Analyst Downgrades, Price Target Cuts MT
25-10-28 HC Wainwright Upgrades Core Scientific to Buy From Neutral, Price Target is $25 MT
25-10-23 Roth Capital Upgrades Core Scientific to Buy From Neutral MT
25-10-22 Coreweave comments on proxy advisor recommendations regarding proposed acquisition of Core Scientific RE
25-10-22 B. Riley Upgrades Core Scientific to Buy From Neutral, Raises Price Target to $30 From $17 MT
25-10-21 Core Scientific Rises Pre-Bell as ISS Recommends Investors Reject CoreWeave Deal MT
25-10-07 CoreWeave Doesn't Plan to Change its Bid for Core Scientific MT
25-08-08 Core Scientific's Q2 revenue misses estimates, net loss widens RE
25-07-10 Macquarie Downgrades Core Scientific to Neutral From Outperform, $15 Price Target MT
25-07-10 B. Riley Downgrades Core Scientific Inc to Neutral From Buy, Price Target is $17 MT
25-07-10 Needham Downgrades Core Scientific to Hold From Buy MT
25-07-08 Core Scientific Shares Fall After Multiple Downgrades MT
25-07-08 Craig-Hallum Downgrades Core Scientific to Hold From Buy MT
25-07-08 BTIG Downgrades Core Scientific to Neutral From Buy MT
25-07-08 HC Wainwright Downgrades Core Scientific to Neutral From Buy MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+124.86%
+10.61%
+33.89%
+120.56%
+18.24%
+110.94%
+72.25%
+24.46%
+56.34%
Average +63.57%
Weighted average by Cap. +42.83%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
16.51USD
Average target price
37.12USD
Spread / Average Target
+124.86%
High Price Target
55.00USD
Spread / Highest target
+233.13%
Low Price Target
28.00USD
Spread / Lowest Target
+69.59%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
  1. Stock Market
  2. Stocks
  3. CORZ Stock
  4. Consensus Core Scientific, Inc.